课题基金 / 基金详情

CORE--MICROINJECTION

CORE--MICROINJECTION
核心--微注射
批准号:
6237092
负责人:
JAMES R FERAMISCO
金额:
$8.37万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-01 至 1998-01-31

项目摘要

项目成果

JAMES R FERAMISCO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Microinjection of proteins and antibodies into living somatic cells is a powerful approach to studying the function of regulatory components of the cells. This method has been particularly useful in studies of oncogene proteins and their function in mammalian cell growth control, where it is difficult to alter the complement of expressed proteins by any other means. By introducing a functional oncogene protein, cell growth can be stimulated in a specific way; whereas by injection of an inhibitory antibody or oligonucleotide, cell growth can be specifically blocked. We will continue to utilize an efficient microinjection facility established during the past project period to study the regulation of nuclear oncogene activity by protein phosphorylation and dephosphorylation. In addition to microinjection of specific neutralizing antibodies and antisense oligonucleotides directed against components of the growth factor signal transduction system, we will microinject various signalling proteins and nuclear oncoproteins. These will include cJun, cJun mutants, PP2A catalytic and regulatory subunits, SH2 domains, tyrosine phosphatases, E2A-Pbx1, vAb1, Ha-Ras, casein kinase II, erkI and erkII. The effects of these macromolecules on cell proliferation and gene expression will be examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Development Component
Cell Imaging, Analysis and Microinjection
Digital Imaging Core
Core--Digital imaging
海外基金